Maximizing efficacy and reducing the emergence of resistance.
about
Application of PK/PD Modeling in Veterinary Field: Dose Optimization and Drug Resistance PredictionApproaches to modelling the human immune response in transition of candidates from research to development.Integration of pharmacokinetic and pharmacodynamic indices of marbofloxacin in turkeys.Rapid eradication of Listeria monocytogenes by moxifloxacin in a murine model of central nervous system listeriosisMolecular analysis of the gyrA and gyrB quinolone resistance-determining regions of fluoroquinolone-resistant Clostridium difficile mutants selected in vitro.Review of moxifloxacin hydrochloride ophthalmic solution in the treatment of bacterial eye infections.Overton's rule helps to estimate the penetration of anti-infectives into patients' cerebrospinal fluidDetection of early liver fibrosis in patients with intestinal schistosomiasis: sonographic and histologic findings in Schistosoma mansoni infection.Effect of treatment duration on pharmacokinetic/pharmacodynamic indices correlating with therapeutic efficacy of ceftazidime in experimental Klebsiella pneumoniae lung infection.Clinical and economic consequences of failure of initial antibiotic therapy for hospitalized patients with complicated skin and skin-structure infections.Randomized, double-blind comparison of once-weekly dalbavancin versus twice-daily linezolid therapy for the treatment of complicated skin and skin structure infections.Budget impact analysis of rapid screening for Staphylococcus aureus colonization among patients undergoing elective surgery in US hospitals .Chemical composition of the essential oil of Lippia gracilis Schauer leaves and its potential as modulator of bacterial resistance.
P2860
Q26753831-1449C871-E130-464D-897A-A57DB2468111Q33661296-16705C23-1C82-4898-ACA9-A31D414DC681Q35127800-6C97FDF6-F78C-4A7C-A354-00FEA7EB0CB6Q36870838-7D18D27E-BDEC-417B-BE1C-FD29710BE956Q37204206-2749DA0A-8D29-4683-9E76-6D8ABE05853DQ37577369-423C575A-E15E-4982-B8B1-7C17A9546029Q40600560-498059A4-ED17-46F5-8337-D956934B3359Q41441261-F85BC78C-0C85-47D8-9D89-9B9A328209C0Q43152276-A438E7FB-DF84-42DE-A56D-B4C00533CF96Q44958309-47F79CD9-C7A3-4C78-941A-8351BE643EE1Q46758156-DE7EC0DE-2829-4CC4-BFB7-05F29AD49C2BQ51112120-A4A9642C-1997-42F5-ABFA-AF43E82DE5AEQ54295998-B0688412-45C3-42E4-8B4C-360D1E1D3BB1
P2860
Maximizing efficacy and reducing the emergence of resistance.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Maximizing efficacy and reducing the emergence of resistance.
@ast
Maximizing efficacy and reducing the emergence of resistance.
@en
type
label
Maximizing efficacy and reducing the emergence of resistance.
@ast
Maximizing efficacy and reducing the emergence of resistance.
@en
prefLabel
Maximizing efficacy and reducing the emergence of resistance.
@ast
Maximizing efficacy and reducing the emergence of resistance.
@en
P356
P1476
Maximizing efficacy and reducing the emergence of resistance.
@en
P356
10.1093/JAC/DKG210
P407
P478
51 Suppl 1
P577
2003-05-01T00:00:00Z